ID: ALA4557239

Max Phase: Preclinical

Molecular Formula: C17H25N

Molecular Weight: 243.39

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC1=C(/C=C/C(C)=C/C=C/CN)C(C)(C)CC=C1

Standard InChI:  InChI=1S/C17H25N/c1-14(8-5-6-13-18)10-11-16-15(2)9-7-12-17(16,3)4/h5-11H,12-13,18H2,1-4H3/b6-5+,11-10+,14-8+

Standard InChI Key:  OALKRYGBFWCZIM-SCVSUVHVSA-N

Associated Targets(non-human)

Lecithin retinol acyltransferase 88 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Retinoid isomerohydrolase 75 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 243.39Molecular Weight (Monoisotopic): 243.1987AlogP: 4.31#Rotatable Bonds: 4
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.64CX LogP: 3.45CX LogD: 1.27
Aromatic Rings: 0Heavy Atoms: 18QED Weighted: 0.73Np Likeness Score: 2.69

References

1.  (2017)  Compounds and methods of treating ocular disorders, 

Source